Oxiplex is designed to be used during lumbar spine surgery. It’s a viscoelastic gel and has been sold in Europe since 2001. FzioMed has been striving since then to get U.S. market approval.
During a special Medical Device Dispute Resolution Panel, the FDA approved the company’s petition for an independent review after an earlier agency denial of the gel.
More Articles on Devices:
Zimmer Spine Launches Viewline MIS Instruments
Roberto Quarta to Serve as Smith & Nephew’s New Chairman
AxoGen Profits Up 60% in Q3 to $2.31M
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
